Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

ClinicalTrials.gov ID: NCT05972044

Public ClinicalTrials.gov record NCT05972044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults With ADHD.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with ADHD.

Study identification

NCT ID
NCT05972044
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
516 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2023 (Actual)
Primary completion
Feb 7, 2025 (Actual)
Completion
Mar 14, 2025 (Actual)
Last update posted
Feb 10, 2026

2023 – 2025

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Clinical Research Site Encino California 91316 —
Clinical Research Site Garden Grove California 92845 —
Clinical Research Site Newport Beach California 92660 —
Clinical Research Site Riverside California 92506 —
Clinical Research Site Santa Ana California 92705 —
Clinical Research Site Sherman Oaks California 91403 —
Clinical Research Site Torrance California 90504 —
Clinical Research Site Walnut Creek California 94596 —
Clinical Research Site Colorado Springs Colorado 80910 —
Clinical Research Site Clermont Florida 34711 —
Clinical Research Site Doral Florida 33122 —
Clinical Research Site Gainesville Florida 32607 —
Clinical Research Site Jacksonville Florida 32256 —
Clinical Research Site Lauderhill Florida 33319 —
Clinical Research Site Miami Lakes Florida 33016 —
Clinical Research Site Orlando Florida 32801 —
Clinical Research Site Marietta Georgia 30060 —
Clinical Research Site Overland Park Kansas 66210 —
Clinical Research Site Boston Massachusetts 02131 —
Clinical Research Site Saint Charles Missouri 63304 —
Clinical Research Site Lincoln Nebraska 68526 —
Clinical Research Site Las Vegas Nevada 89102 —
Clinical Research Site Las Vegas Nevada 89128 —
Clinical Research Site Berlin New Jersey 08009 —
Clinical Research Site Cherry Hill New Jersey 08002 —
Clinical Research Site Princeton New Jersey 08540 —
Clinical Research Site Mount Kisco New York 10549 —
Clinical Research Site New York New York 10128 —
Clinical Research Site Raleigh North Carolina 27609 —
Clinical Research Site Cincinnati Ohio 45219 —
Clinical Research Site Kettering Ohio 45439 —
Clinical Research Site Oklahoma City Oklahoma 73116 —
Clinical Research Site Media Pennsylvania 19063 —
Clinical Research Site North Charleston South Carolina 29405 —
Clinical Research Site Memphis Tennessee 38119 —
Clinical Research Site Austin Texas 78737 —
Clinical Research Site Bellaire Texas 77401 —
Clinical Research Site Dallas Texas 75243 —
Clinical Research Site Dallas Texas 75251 —
Clinical Research Site San Antonio Texas 78229 —
Clinical Research Site Draper Utah 84020 —
Clinical Research Site Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05972044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05972044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →